Furthermore, the number of tryptase− C3+ cells did not significantly change with melanoma progression, while C3+ MAMCs were significantly increased in stage IV (50 cells/mm2, SD: 32.2, n = 20) in comparison to healthy C3+ MCs (21.2 cells/mm2, SD: 9.8, n = 10). Here, C3 is linked to melanoma.